At the end of two weeks of non-stop second quarter earnings reports, S&P Capital IQ expects a decline of -0.71% year-over-year in the S&P 500 Index for the quarter, a figure it…
The three major US stock indexes opened modestly lower this morning as there was little news out of Europe and Asian markets closed mixed. Traders were waiting to hear more from Fed…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for the first quarter of 2012. The top five sellers include drugs from…
Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but missed slightly on revenues. The drug maker reported adjusted diluted EPS of…
The three major US stock indexes opened higher this morning in advance of Fed Chairman Ben Bernanke’s semi-annual report to Congress and following some data on inflation (more coverage here), industrial production,…
Wednesday is going to mark yet another important day for the early wave of key earnings for this earnings season. The second quarter became more challenging for many companies as we noted…
News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment has the entire drug sector up in arms as it pertains to…
Health care products maker Abbott Laboratories (NYSE: ABT) received US Food and Drug Administration approval to market its new glucose monitoring system for the nearly 26 million US diabetics who take insulin.…
Paul Ausick Abbott Laboratories (NYSE: ABT) may be in the midst of a long-term restructuring, but the company turned in earnings growth of 11.5% to $1.45 EPS. The analyst consensus estimate was $1.44 per…
Jon C. Ogg Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that fourth-quarter revenue from its Provenge prostate-cancer vaccine would exceed earlier forecasts. Looking…
It’s that time of year again, when proxies are released and many business publications run lists of the highest paid CEOs at America’s large public companies. The compensation figures are extraordinarily high,…
Stocks opened down this morning following the earnings report Apple Inc. (NASDAQ: AAPL) after markets closed yesterday. Moody’s downgrade of Spain’s sovereign debt also weighed on the opening.  The Consumer Price Index for…
Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what about when a company decides to unlock shareholder value by breaking itself…
MSNBC: US housing starts jumped in September http://on.msnbc.com/pxVyNE NYT: Olympus Backtracks on Payments http://nyti.ms/pAPNmD CNNMoney: Apple 2.0: Apple’s big miss: The analysts weigh in http://bit.ly/r7OZMN $AAPL FT: Olympus contradicts chairman over fees…
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession. They…
